Phosphorylation of Fli1 at Threonine 312 by Protein Kinase C δ Promotes Its Interaction with p300/CREB-Binding Protein-Associated Factor and Subsequent Acetylation in Response to Transforming Growth Factor β

REFERENCES

• Asano, Y., J. Czuwara, and M. Trojanowska. 2007. Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation. J. Biol. Chem. 282:34672–34683.
   PubMedGoogle Scholar
• Asano, Y., H. Ihn, K. Yamane, M. Jinnin, Y. Mimura, and K. Tamaki. 2004. Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts. J. Immunol. 172:7123–7135.
   PubMedGoogle Scholar
• Asano, Y., H. Ihn, K. Yamane, M. Kubo, and K. Tamaki. 2004. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J. Clin. Investig. 113:253–264.
   PubMed Web of Science ®Google Scholar
• Asano, Y., M. Markiewicz, M. Kubo, G. Szalai, D. K. Watson, and M. Trojanowska. 2009. Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin. Mol. Cell. Biol. 29:425–434.
   PubMed Web of Science ®Google Scholar
• Bailly, R.-A., R. Bosselut, J. Zucman, F. Cormier, O. Delattre, M. Roussel, G. Thomas, and J. Ghysdael. 1994. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14:3230–3241.
   PubMed Web of Science ®Google Scholar
• Ben-David, Y., E. B. Giddens, and A. Bernstein. 1990. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc. Natl. Acad. Sci. USA 87:1332–1336.
   PubMed Web of Science ®Google Scholar
• Ben-David, Y., E. B. Giddens, K. Letwin, and A. Bernstein. 1991. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:908–918.
   PubMed Web of Science ®Google Scholar
• Bhowmick, N. A., M. Ghiassi, M. Aakre, K. Brown, V. Singh, and H. L. Moses. 2003. TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc. Natl. Acad. Sci. USA 100:15548–15553.
   PubMed Web of Science ®Google Scholar
• Chen, L. F., S. A. Williams, Y. Mu, H. Nakano, J. M. Duerr, L. Buckbinder, and W. C. Greene. 2005. NF-κB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25:7966–7975.
   PubMed Web of Science ®Google Scholar
• Czuwara-Ladykowska, J., F. Shirasaki, P. Jackers, D. K. Watson, and M. Trojanowska. 2001. Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J. Biol. Chem. 276:20839–20848.
   PubMed Web of Science ®Google Scholar
• Daniels, C. E., M. C. Wilkes, M. Edens, T. J. Kottom, S. J. Murphy, A. H. Limper, and E. B. Leof. 2004. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J. Clin. Investig. 114:1308–1316.
   PubMed Web of Science ®Google Scholar
• Delattre, O., J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, et al. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162–165.
   PubMed Web of Science ®Google Scholar
• Douillet, C. D., V. Velarde, J. T. Christopher, R. K. Mayfield, M. E. Trojanowska, and A. A. Jaffa. 2000. Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK. Am. J. Physiol. Heart Circ. Physiol. 279:H2829–H2837.
   PubMedGoogle Scholar
• Hart, A., F. Melet, P. Grossfeld, K. Chien, C. Jones, A. Tunnacliffe, R. Favier, and A. Bernstein. 2000. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 13:167–177.
   PubMed Web of Science ®Google Scholar
• Hayashida, T., A. C. Poncelet, S. C. Hubchak, and H. W. Schnaper. 1999. TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int. 56:1710–1720.
   PubMed Web of Science ®Google Scholar
• Hollenhorst, P. C., D. A. Jones, and B. J. Graves. 2004. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res. 32:5693–5702.
   PubMed Web of Science ®Google Scholar
• Jackson, D. N., and D. A. Foster. 2004. The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival. FASEB J. 18:627–636.
   PubMed Web of Science ®Google Scholar
• Jimenez, S. A., S. Gaidarova, B. Saitta, N. Sandorfi, D. J. Herrich, J. C. Rosenbloom, U. Kucich, W. R. Abrams, and J. Rosenbloom. 2001. Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts. J. Clin. Investig. 108:1395–1403.
   PubMed Web of Science ®Google Scholar
• Jinnin, M., H. Ihn, Y. Asano, K. Yamane, M. Trojanowska, and K. Tamaki. 2006. Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J. Cell. Physiol. 206:718–727.
   PubMedGoogle Scholar
• Jinnin, M., H. Ihn, Y. Mimura, Y. Asano, K. Yamane, and K. Tamaki. 2005. Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res. 33:3540–3549.
   PubMedGoogle Scholar
• Jinnin, M., H. Ihn, K. Yamane, Y. Mimura, Y. Asano, and K. Tamaki. 2005. Alpha2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts. Nucleic Acids Res. 33:1337–1351.
   PubMedGoogle Scholar
• Kubo, M., J. Czuwara-Ladykowska, O. Moussa, M. Markiewicz, E. Smith, R. M. Silver, S. Jablonska, M. Blaszczyk, D. K. Watson, and M. Trojanowska. 2003. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am. J. Pathol. 163:571–581.
   PubMedGoogle Scholar
• Lee, K. A., A. Bindereif, and M. R. Green. 1988. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech. 5:22–31.
   PubMedGoogle Scholar
• Massague, J. 1998. TGF-beta signal transduction. Annu. Rev. Biochem. 67:753–791.
   PubMed Web of Science ®Google Scholar
• Masuya, M., O. Moussa, T. Abe, T. Deguchi, T. Higuchi, Y. Ebihara, D. D. Spyropoulos, D. K. Watson, and M. Ogawa. 2005. Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice. Blood 105:95–102.
   PubMedGoogle Scholar
• Mishra, R., L. Zhu, R. L. Eckert, and M. S. Simonson. 2007. TGF-beta-regulated collagen type I accumulation: role of Src-based signals. Am. J. Physiol. Cell Physiol. 292:C1361–C1369.
   PubMedGoogle Scholar
• Moustakas, A., and C. H. Heldin. 2005. Non-Smad TGF-beta signals. J. Cell Sci. 118:3573–3584.
   PubMed Web of Science ®Google Scholar
• Nakerakanti, S. S., B. Kapanadze, M. Yamasaki, M. Markiewicz, and M. Trojanowska. 2006. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J. Biol. Chem. 281:25259–25269.
   PubMedGoogle Scholar
• Pannu, J., Y. Asano, S. Nakerakanti, E. Smith, S. Jablonska, M. Blaszczyk, P. Ten Dijke, and M. Trojanowska. 2008. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Arthritis Rheum. 58:2528–2537.
   PubMed Web of Science ®Google Scholar
• Pannu, J., H. Gardner, J. R. Shearstone, E. Smith, and M. Trojanowska. 2006. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: a model of scleroderma. Arthritis Rheum. 54:3011–3021.
   PubMedGoogle Scholar
• Perillan, P. R., M. Chen, E. A. Potts, and J. M. Simard. 2002. Transforming growth factor-beta 1 regulates Kir2.3 inward rectifier K+ channels via phospholipase C and protein kinase C-delta in reactive astrocytes from adult rat brain. J. Biol. Chem. 277:1974–1980.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, K., J. E. Herrera, S. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Anderson, and E. Appella. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12:2831–2841.
   PubMed Web of Science ®Google Scholar
• Sato, M., D. Shegogue, E. A. Gore, E. A. Smith, P. J. McDermott, and M. Trojanowska. 2002. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts. J. Investig. Dermatol. 118:704–711.
   PubMedGoogle Scholar
• Shirasaki, F., H. A. Makhluf, C. LeRoy, D. K. Watson, and M. Trojanowska. 1999. Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 18:7755–7764.
   PubMedGoogle Scholar
• Soltoff, S. P. 2007. Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol. Sci. 28:453–458.
   PubMed Web of Science ®Google Scholar
• Spyropoulos, D. D., P. N. Pharr, K. R. Lavenburg, P. Jackers, T. S. Papas, M. Ogawa, and D. K. Watson. 2000. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol. Cell. Biol. 20:5643–5652.
   PubMedGoogle Scholar
• Steinberg, S. F. 2004. Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem. J. 384:449–459.
   PubMed Web of Science ®Google Scholar
• Tamaki, T., K. Ohnishi, C. Hartl, E. C. LeRoy, and M. Trojanowska. 1995. Characterization of a GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the alpha 2(I) collagen gene in human fibroblasts. J. Biol. Chem. 270:4299–4304.
   PubMedGoogle Scholar
• Torgersen, M. L., S. Walchli, S. Grimmer, S. S. Skanland, and K. Sandvig. 2007. Protein kinase Cdelta is activated by Shiga toxin and regulates its transport. J. Biol. Chem. 282:16317–16328.
   PubMedGoogle Scholar
• Varga, J. 2002. Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum. 46:1703–1713.
   PubMedGoogle Scholar
• Varga, J. A., and M. Trojanowska. 2008. Fibrosis in systemic sclerosis. Rheum. Dis. Clin. N. Am. 34:115–143.
   PubMed Web of Science ®Google Scholar
• Verrecchia, F., and A. Mauviel. 2007. Transforming growth factor-beta and fibrosis. World J. Gastroenterol. 13:3056–3062.
   PubMed Web of Science ®Google Scholar
• Yi, J. Y., I. Shin, and C. L. Arteaga. 2005. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J. Biol. Chem. 280:10870–10876.
   PubMed Web of Science ®Google Scholar
• Yu, L., M. C. Hebert, and Y. E. Zhang. 2002. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21:3749–3759.
   PubMed Web of Science ®Google Scholar
• Zdunek, M., S. Silbiger, J. Lei, and J. Neugarten. 2001. Protein kinase CK2 mediates TGF-beta1-stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int. 60:2097–2108.
   PubMed Web of Science ®Google Scholar
• Zhang, L., C. J. Duan, C. Binkley, G. Li, M. D. Uhler, C. D. Logsdon, and D. M. Simeone. 2004. A transforming growth factor beta-induced Smad3/Smad4 complex directly activates protein kinase A. Mol. Cell. Biol. 24:2169–2180.
   PubMed Web of Science ®Google Scholar
• Zhang, X. K., and D. K. Watson. 2005. The FLI-1 transcription factor is a short-lived phosphoprotein in T cells. J. Biochem. (Tokyo) 137:297–302.
   PubMedGoogle Scholar